Amy Ennis was only 38 years old when she was diagnosed with stage III
#colorectalcancer
, eventually metastasizing to her lungs. After several rounds of treatment, Ennis has no sign of disease — and today, she's paying it forward.
🚨 BREAKING NEWS 🚨 We are thrilled to announce that Dana-Farber’s William G. Kaelin Jr., MD, has been named one of three researchers awarded the 2019
#NobelPrize
in Physiology or Medicine! Learn more:
A message from Dana-Farber nurses, clinical assistants, and pharmacy and environmental services staff. Please help us keep our infusion patients safe.
#stayhome
Breaking News: Dana-Farber Cancer Institute has announced a new collaboration with
@BIDMChealth
and plans to build the region’s only free-standing inpatient hospital for adult cancer patients.
The proposed state-of-the-art cancer center will transform the future of patient care…
We are saddened by the unexpected death of Dana-Farber’s David M. Livingston, MD, a great scientist, colleague, mentor, and friend, who made countless contributions to cancer research in his more than 45 years at the Institute.
A team of researchers led by Dana-Farber have identified 34 new genes that are associated with an increased risk for developing earliest-stage ovarian cancer.
“There’s a horrible stigma about how to talk about
#cancer
: people are afraid to have conversations, but I want to normalize it,” says 26-year-old Chloe Svolos, Dana-Farber patient and employee.
#HodgkinLymphoma
Two years after being given six months to live, Michael Mullan’s cancer is still at bay because of
#immunotherapy
and targeted chemotherapy – and through it all, he achieved one of his dreams: graduating from Harvard Law School.
We are thrilled that Todd Golub of
@DanaFarber
has been named director of
@broadinstitute
-- an outstanding leader who will help advance the biology and treatment of human disease, using genomics to develop new therapies. Congratulations Todd!!
#BreakingNews
- The 2019
#NobelPrize
in Physiology awarded to Dana-Farber researcher William G. Kaelin, Jr for "discoveries of how cells sense and adapt to oxygen availability." Sir Peter J. Ratcliffe and Gregg L. Semenza also jointly awarded.
Today, we celebrate
#InternationalChildhoodCancerDay
, a day to raise awareness about
#childhoodcancer
and express support for children with cancer, survivors, and their families. Learn how we're working to improve outcomes & survival rates worldwide:
#ICCD
New study by Dana-Farber investigators has identified a critical molecular pathway that drives NK cell responses against viral infections & cancer. This insight could aid scientists’ efforts to harness NK cells as a form of
#immunotherapy
to treat tumors.
Dana-Farber scientists have demonstrated that an
#AI
tool can perform as well as human reviewers – and much more rapidly - in extracting clinical information regarding changes in tumors from unstructured radiology reports for patients with lung cancer.
Congratulations! After fulfilling a promise she made to herself when diagnosed with leukemia by running the
@bostonmarathon
in April, Mary ran the
@nycmarathon
this past Sunday- once again in support of Dana-Farber!
What a wonderful moment for the Dana-Farber community! We are so proud of
#Nobel
laureate Dr. William Kaelin, pictured being presented with a
#NobelPrize
medal and diploma by the King of Sweden today in Stockholm.
Thrilled to receive our first shipment of the
#COVID19
#vaccine
today and will start giving to our staff tomorrow. Expecting more doses in the coming weeks & months. While we celebrate this great news, it’s still important to wear a mask and physical distance.
#COVID19Vaccine
.
@DrEricWiner
, diagnosed with hemophilia at 13 months old, shares how hospitals & doctors ignited his drive to become a physician, and how his diagnoses with
#HIV
, hepatitis C, and treatment complications did not stop him from having a family and career.
.
@Gary_Tanguay
of
@NBCSBoston
was surprised by a group of nurses bearing champagne and a baseball-themed cake yesterday to help celebrate Tanguay’s final chemotherapy infusion for non-Hodgkin lymphoma. 🍾⚾️ The party took place in Dana-Farber's Yawkey Center for Cancer Care.
After 6 years of treatment failed to stop the growth of Frances Zichichi's
#braintumor
, she went on an immunotherapy
#clinicaltrial
—and is now tumor-free. Dana-Farber researchers have launched an effort to discover the source of her tumor’s vulnerability.
We're still buzzing over here at Dana-Farber after Dr. William Kaelin Jr.'s
#NobelPrize
win! Dr. Kaelin enjoyed a week of celebrations with colleagues and his lab staff. 🎉🍾
@kaelin_lab
"To every young girl out there, every child with an inkling that what she wants to do is impact the field of science, research, academia, medicine... I say go for it. We need more of you." Allison O'Neill, MD, Clinical Director of the Solid Tumor Program, on
#IWD2019
.
Two years after being given six months to live, Mullan’s cancer is still at bay because of
#immunotherapy
and targeted chemotherapy – and through it all, he achieved one of his dreams: graduating from
@Harvard
Law School.
On National Cancer Survivors Day, we honor everyone who has experienced cancer, whether newly diagnosed or years out of treatment. We know it takes resilience, strength, humor, and bravery to get through treatment, and we see it in our patients every day.
#NCSD2018
Two years after being given six months to live, Michael Mullan’s cancer is still at bay because of
#immunotherapy
and targeted chemotherapy – and through it all, he achieved one of his dreams: graduating from
@Harvard_Law
.
Last night
@TDGarden
, Bruce Springsteen gave a shout out to Dana-Farber, the Yawkey Center, and Dr. Paul Richardson before singing his hit song “Thunder Road.” We love you too,
@Springsteen
!
Forced to rely on her wheelchair and walker to move about, Kelly Lamphere’s multiple myeloma was showing no signs of improvement. After receiving CAR T-cell therapy and chemotherapy, Kelly is moving around on her own again.
Each time a long-term pediatric patient in Dana-Farber/
@BostonChildrens
oncology program is discharged from the hospital, a crowd of nurses and caregivers gather to celebrate the end of treatment with a Bubble Parade! Help us share this heartwarming moment in honor of
#CCAM
.
Dana-Farber receives $20 million gift to establish the Saverin Breast Cancer Research Fund dedicated to extending lives of metastatic
#breastcancer
patients. The commitment is the largest individual gift for breast cancer research in Dana-Farber’s history.
Earlier this month, Dana-Farber held its 28th Annual Discovery Celebration in Palm Beach. Our President & CEO Laurie Glimcher, MD, was joined by Institute Trustee Robert Kraft and Pre-Celebration Dinner Keynote Speaker Katie Couric.
Thanks to Dunkin’s generosity our Dana-Farber staff is running on
@dunkindonuts
! Dunkin stopped by Dana-Farber this morning to provide our hardworking staff with some much-needed caffeine during these uncertain times. Thank you for spreading joy this morning!
Congratulations to Monica Bertagnolli, MD, on being confirmed by the U.S. Senate to lead the
@NIH
.
As leader of the
@theNCI
, she demonstrated she has the talent to advance the mission of the agency. We’re excited to witness her impact on the health of our nation.
Congratulations to Dana-Farber's Daphne Adele Haas-Kogan, M.D., and Catherine J. Wu, M.D., who have been elected to the National Academy of Medicine, one of the highest honors in the field of health and medicine.
Spotlighting the new
#NobelPrize
display at
@DanaFarber
in honor of 2019 Nobel Laureate, William G. Kaelin, Jr., MD. A tremendous honor to share with our staff, patients and their families as we celebrate Dr. Kaelin's discovery!
.
@DrEricWiner
, diagnosed with hemophilia at 13 months old, shares how hospitals & doctors ignited his drive to become a physician, and how his diagnoses with
#HIV
, hepatitis C, and treatment complications did not stop him from having a family and career.
Scientists at Dana-Farber Cancer Institute have developed a drug that potently neutralizes SARS-CoV-2, the
#COVID19
coronavirus, and is equally effective against the
#Omicron
variant and every other tested variant.
Dana-Farber is thrilled to share the news that Nature Biotech named Loren Walensky of Dana-Farber/Boston Children’s (
@DFBC_PedCare
) one of the world’s Top 20 Translational Researchers of 2019!
We celebrate
@DrIbram
and our Dana-Farber patients as they share their journeys with
#colorectalcancer
in a groundbreaking feature for
@GQMagazine
to shed light on the critical work being done to raise awareness for diverse patient populations:
#CRCSM
.
@Gary_Tanguay
of NBC Sports Boston usually broadcasts from a studio, but today he reported “live” from Dana-Farber during his final chemotherapy infusion for Non-Hodgkin lymphoma.
We love you too, Gary! ❤️
When Jane MacKenzie realized she had lost her
#wedding
band during breast cancer treatment, staff at Dana-Farber immediately set out to find it. Combing through 9 bags of garbage, Bill Mason of Security found MacKenzie’s 💍 in the last one – which earned him a hug and brownies.
We are proud to announce our bold new look! Our updated logo represents Dana-Farber’s blend of innovative science and exceptional patient care that has been transforming medicine for more than 70 years. Learn more:
Congrats and thank you to the committed
@PanMass
riders, volunteers, donors, and sponsors. We cannot thank you enough for your time and dedication in our fight against cancer.
#PMC40
#PMC2019
“This is the first time it has been shown that a vaccine can generate immune cells against the tumor that can traffic from the bloodstream into a glioblastoma tumor.” Dana-Farber scientists say neoantigen vaccine spurs immune response in
#glioblastoma
. 🔬
BREAKING: President-elect Joe Biden to announce he will nominate geneticist
@eric_lander
to be Director of White House science office. Lander is director of
@broadinstitute
and former head of President’s science advisory council under Obama. More to come…
“You’ve got to have some objective when you get up in the morning, a purpose and a place to be.” 95-year-old Sandy Cunningham has spent the last 20 years serving lunch to cancer patients as a weekly volunteer at Dana-Farber.
#NationalVolunteerWeek
Thank you to the Massachusetts National Guard who marched 4.5 miles to deliver holiday cheer and toys to our pediatric patients last week! ❤️🎁
#RuckMarch
CAR T-cell therapy is a promising treatment for some of the most challenging cases we face in pediatric acute lymphoblastic leukemia (ALL). Lewis Silverman, MD, explains what makes this treatment so significant and what it means for
#leukemia
patients.
New research in
@TheLancetOncol
shows HLA allele, HLA-A*03, is associated w/poor clinical outcomes for cancer patients receiving immunotherapy. The findings support HLA-A*03 as a potential biomarker for immunotherapy response.
Congratulations to our friend
@katiecouric
who was honored by the
@smithsonian
last night for her role as a journalist in advocating for cancer awareness and research. Our doctors, researchers, staff, and patients are grateful for her tireless advocacy and support.
Two years after being given six months to live, Michael Mullan’s cancer is still at bay because of
#immunotherapy
and targeted chemotherapy – and through it all, he achieved one of his dreams: graduating from Harvard Law School.
Congratulations to
@IreneGhobrial
recipient of the Jan Gosta Waldenström’s Award, honoring a lifetime of outstanding scientific and medical contributions to the advancement of Waldenström’s Macroglobulinemia.
They really are heroes among us! Proud to see Dana-Farber’s George and Jean Canellos honored for their lifelong dedication to cancer research and care at tonight’s
@Celtics
game! ☘️
This Childhood Cancer Awareness Month, we are celebrating our childhood cancer heroes – the children affected by cancer and their families, and the clinicians caring for them on their journeys.
Congratulations to
@DanaFarber
’s Cigall Kadoch, PhD, and Eric S. Fischer, PhD, finalists for the 2023 Blavatnik National Awards for Young Scientists which honor outstanding scientists and engineers under the age of 42.
@blavatnikawards
@NYASciences
Congratulations to Dana-Farber's Benjamin Ebert, MD, PhD, and Matthew Meyerson, MD, PhD, for election to the National Academy of Medicine!
@theNAMedicine
Congratulations to our president and CEO, Dr. Laurie H. Glimcher, on being named to
@modrnhealthcr
's 2018 list of the 100 Most Influential People in Healthcare!
#MHmostinfluential
Dana-Farber has received a $5 million gift from the Benderson family of Sarasota, Fl in support of triple negative breast cancer. This generous donation will help researchers deliver novel + promising therapies to patients living with this often challenging form of breast cancer.
With the help of Profile, our physician scientists are able to uncover unique abnormalities in tumors to better match patients to targeted therapies. And while many patients benefit from Profile, few involve a turnabout as dramatic as this one:
Congratulations to our nurses and staff! A moment of immense pride as Dana-Farber is recognized for excellence in nursing practice and patient care. 🎊🎉
#MagnetDesignation
#DFCInursing
@ANCCofficial
COVID 19 will not take away the smiles from underneath our masks, & it certainly will never stop us from dancing🎗💛 Orli was pumped to get her medical team into her TikTok before treatment started.
Turn up the volume and feel the JOY💛🎶
These are the moments we need & love.
For the 23rd consecutive year, Dana-Farber Brigham Cancer Center is recognized as a
#BestHospitals
for cancer care by
@usnews
@USNewsHealth
.
This year, ranked as the best hospital for cancer care in New England and
#5
in the nation.
Today is Dana-Farber Cancer Institute Day in the City of Boston! Thanks to
@MayorWu
for issuing this proclamation as we mark our 75th anniversary. Learn more:
#DanaFarber75
CAR T-cell therapy is a promising treatment for some of the most challenging cases we face in pediatric acute lymphoblastic leukemia (ALL). Lewis Silverman, MD, explains what makes this treatment so significant and what it means for
#leukemia
patients.
#WorldCancerDay
Zuzana Tothova, MD, PhD, heads
@TothovaLab
, sees patients, & advises students in the
@Harvard
/
@MIT
MD-PhD program of which she is a product. In recounting her odyssey from Slovakia to Dana-Farber, Tothova often says modestly, “I was very lucky.”
Dana-Farber Cancer Institute and Oncoclínicas & Co, the largest group dedicated to cancer in Latin America, announce the expansion of their collaboration with the opening of the first Oncoclínicas Cancer Center.
Rizwan Romee, MD, is a medical oncologist at Dana-Farber and treats patients with advanced blood cancers such as leukemia and myelodysplastic syndrome.
A finding by Dana-Farber researchers may help explain why
#multiplemyeloma
often rebounds after drug treatment. The research also suggests combinations of drugs that can prevent such recurrence.
On National Cancer Survivors Day, we honor everyone who has experienced cancer, whether newly diagnosed or years out of treatment. We know it takes resilience and bravery to get through treatment, and we see it in our patients every day.
#NCSD2019
After experiencing two relapses in three years, Maddie Carlson entered into an immunotherapy clinical trial at Dana-Farber/Boston Children’s to treat her Ewing sarcoma. Today, she is disease-free.